Fortunately in this low interest rate environment, there are plenty of ASX dividend shares that offer generous yields.
Two that are buy-rated and have good yields are listed below. Here's what you need to know about them:
Accent Group Ltd (ASX: AX1)
The first ASX dividend share to look at is this footwear focused retailer. Its shares have been hammered this year due to its disappointing performance during the first half caused by lockdowns and other COVID headwinds.
While this is disappointing, the team at Bell Potter remain positive on its longer term outlook and appear to believe it could be a buying opportunity for investors. Especially if you're a patient income investor.
While Bell Potter now only expects a fully franked dividend of 5.4 cents per share in FY 2022, it is forecasting a big rebound in FY 2023 and a dividend payment of 11 cents per share. Based on the current Accent share price of $2.06, this will mean yields of 2.6% and 5.3%, respectively.
Bell Potter has a buy rating and $2.75 price target on Accent's shares.
Centuria Industrial REIT (ASX: CIP)
Another ASX dividend share to look at is Centuria Industrial. It is a leading property company with a focus on high quality industrial assets. The majority of the company's tenant base is linked to the production, packaging and distribution of consumer staples, telecommunications, and pharmaceuticals.
Demand for Centuria Industrial's properties has been strong this year, which led to it reporting a weighted average lease expiry (WALE) of 8.9-years with a 99.2% portfolio occupancy earlier this week.
This strong form allowed the company to upgrade its guidance for funds from operations (FFO) in FY 2022. Management now expects FFO to be no less than 18.2 cents per share, up from its prior guidance of 18.1 cents per share.
As for dividends, the company is guiding to a distribution of 17.3 cents per share in FY 2022. Based on the current Centuria Industrial share price of $3.93, this will mean a yield of 4.4%.
Centuria Industrial's update went down well with the team at Morgan Stanley. In response, the broker retained its overweight rating and lifted its price target to $4.35.
